IBUPROFEN OVERDOSE AND EXPOSURE INUTERO - RESULTS FROM A POSTMARKETING VOLUNTARY REPORTING SYSTEM

被引:21
作者
BARRY, WS
MEINZINGER, MM
HOWSE, CR
机构
关键词
D O I
10.1016/S0002-9343(84)80016-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:35 / 39
页数:5
相关论文
共 31 条
[1]  
CANTOR B, 1980, J REPROD MED, V24, P220
[2]   DRUG-INDUCED ILLNESS LEADING TO HOSPITALIZATION [J].
CARANASOS, GJ ;
STEWART, RB ;
CLUFF, LE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 228 (06) :713-717
[3]   INHIBITION OF PROSTAGLANDIN SYNTHESIS AND CONTRACTILITY IN RABBIT AND RAT UTERUS BY IBUPROFEN [J].
CSAPO, AI .
PROSTAGLANDINS, 1977, 13 (04) :735-743
[4]  
CULBERT MF, 1974, CURR MED RES OPIN, V2, P600
[5]   POST-MARKETING SURVEILLANCE [J].
CULLITON, BJ ;
WATERFALL, WK .
BRITISH MEDICAL JOURNAL, 1980, 280 (6224) :1175-1176
[6]  
DUCROT H, 1978, P INT FEDERATION INF, P115
[7]   ADVERSE DRUG-REACTIONS - A CONTINUING PROBLEM [J].
FELDMANN, EG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (06) :585-585
[8]  
GILL D, 1976, J IRISH MED ASS, V69, P375
[9]   THE SENSITIVITY OF A VOLUNTARY DRUG EXPERIENCE REPORTING SYSTEM [J].
HOWSE, CR ;
LINDEN, CV ;
BARRY, WS .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1980, 14 (06) :439-440
[10]  
INGELFINGER JA, 1981, CLIN PHARM THER, V29, P510